상세 보기
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
- Kim, Yoo-Yeon;
- Choe, Young June;
- Kim, Jia;
- Kim, Ryu Kyung;
- Jang, Eun Jung;
- 외 4명
Citations
WEB OF SCIENCE
16Citations
SCOPUS
16초록
National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05-0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67-0.84).
키워드
Coronavirus; COVID-19; SARS-CoV-2; Vaccine; Booster; VARIANT
- 제목
- Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
- 제목 (타언어)
- Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
- 저자
- Kim, Yoo-Yeon; Choe, Young June; Kim, Jia; Kim, Ryu Kyung; Jang, Eun Jung; Lee, Hyeryeon; Yi, Seonju; Lee, Sangwon; Park, Young-Joon
- 발행일
- 2023-03
- 유형
- Article
- 권
- 38
- 호
- 11
- 페이지
- 1 ~ 6
- 언어
- ENG
- 출판사
- 대한의학회
- 발행국가
- 대한민국
- 분량
- 6 페이지
- ISSN
- E 1598-6357
P 1011-8934